Employers have great potential to influence distribution, purchasing and brokerage actors to address rising health care costs. With patients unable to negotiate for themselves, employers can take a more aggressive stance in negotiating with suppliers and insurers to price drugs competitively. Read more from the Harvard Business Review here.
Last Updated on May 7, 2020 by Aimed Alliance
